Table: Kobayashi Pharmaceutical -2016 group results
Feb 1 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Mar 31, 2016 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 120.05 137.21 150.00 63.50
(+6.9 pct)
Operating 17.41 18.26 20.00 7.60
(+1.9 pct)
Recurring 19.50 17.95 21.00 7.10
(-4.7 pct)
Net
Net 14.32 13.47 15.10 5.00
(+8.2 pct)
EPS 179.12 yen 165.56 yen 191.64 yen 63.46 yen
EPS Diluted 178.86 yen 165.30 yen
Ann Div 52.00 yen 96.00 yen 52.00 yen
-Q2 Div 25.00 yen 48.00 yen 26.00 yen
-Q4 Div 27.00 yen 48.00 yen 26.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows